This content is restricted.
Brief
The Commission Implementing Regulation (EU) 2024/2563 amends Implementing Regulation (EU) 2022/1646 to clarify content and submission requirements for national risk-based control plans and randomised surveillance plans. The Regulation ensures consistency in data reporting, specifies minimum sampling frequencies, and adjusts rules related to pharmacologically active substances. The main purpose of this Regulation is to amend the existing implementing regulation as regards additional content of the national risk-based control plan and the national randomized surveillance plan.
Highlights content goes here...
This content is restricted.

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested